In vitro and in vivo complex formations of polymyxin B and lipopolysaccharides (LPS) from resistant and sensitive cells of Serratia marcescens were studied by polyacrylamide gel electrophoresis in sodium dodecyl sulfate and electron microscopy. In vitro treatment of LPS from resistant cells with polymyxin B gave two populations of spherical complexes of different molecular weights as determined electrophoretically. Similar treatment of LPS from sensitive cells resulted in dissociation of the LPS-protein and subsequent complexing with the LPS moiety into stable spheres.
(Received for publication January 27, 1976) In vitro and in vivo complex formations of polymyxin B and lipopolysaccharides (LPS) from resistant and sensitive cells of Serratia marcescens were studied by polyacrylamide gel electrophoresis in sodium dodecyl sulfate and electron microscopy. In vitro treatment of LPS from resistant cells with polymyxin B gave two populations of spherical complexes of different molecular weights as determined electrophoretically. Similar treatment of LPS from sensitive cells resulted in dissociation of the LPS-protein and subsequent complexing with the LPS moiety into stable spheres.
In vivo treatment of resistant cells with polymyxin B resulted in LPS-polymyxin B complexes which were comparatively smaller and existed in two morphological forms: spheres and linear ribbons.
LPS from the sensitive cells were degraded extensively into small rods and an amorphous mass by the in vivo polymyxin B treatment.
In both systems, the electrophoretic results consistently matched the electron microscopic evidences for complex formation of LPS with polymyxin B. It is suggested that the disruptive effects of polymyxin B on LPS in the outer membrane of S. marcescens may be the explanation for the change in permeability barrier in the resistant cells and disorganization of the outer membrane and subsequent death in the sensitive cells. Furthermore, the ability of the LPS to complex with the polymyxin B molecules in resistant cells may be the basis of their resistance to the antibiotic.
Polymyxin B, a cationic polypeptide antibiotic, interacts with various anionic cellular components of gram-negative bacteria such as lipopolysaccharide (LPS),1,1) phospholipids (PL),3-6) deoxyribonucleic acid (DNA) 7-9) and ribosomes.8-10) Polymyxin B treatment of LPS isolated from susceptible bacteria results in a breakdown of the LPS molecule (in vitro effect).11) When whole cells are treated with the antibiotic, blebs are formed on the outer membrane of the cell envelope7. [12] [13] [14] and subsequently, disorganization of the outer membrane occurs if the cells are susceptible to the antibiotic.
Although the formation of the blebs in the outer membrane has been suggested to be caused by an aggregation of the antibiotic with outer membrane components such as LPS and PL9) (in vivo effect), direct evidences for the formation of such aggregates or complexes have not been shown, nor was the sequence of events from the moment of complex formation to the disorganization of the outer membrane described. In this communication, we report the electrophoretic and electron microscopic evidences of the in vitro and in vivo formation of complexes between polymyxin B and LPS from cells of Serratia marcescens, which were either resistant or sensitive to the antibiotic. . All strains were grown in an enriched medium of casamino acids as previously described,15,16) with aeration at room temperature and harvested after 17-19 hours of growth. Cells harvested from 1 liter of medium were treated with 20 mg of polymyxin B sulfate (Burroughs Wellcome) in 75 ml of 0.9 % saline at pH 7.3 for 1 minute at 37°C according to the method of CERNY and TEUBER. 17) Lipopolysaccharide was extracted from polymyxin B treated and untreated cells of the resistant and sensitive strains of S. marcescens by the modified hot aqueous phenol method of WESTPHAL as previously described.16) In vitro complex formation of polymyxin B with LPS was carried out by adding 1 mg of LPS form either resistant or sensitive cells to 0.2 ml 0.9 saline solution containing 0.05 mg of polymyxin B, pH 7.3. After mixing for 1 minute at 37°C, the LPS-polymyxin B solution was either placed on a carbon-coated Formvar grid for electron-microscopy or added to a solubilizing solvent for polyacrylamide gel electrophoresis (PGE) in sodium dodecyl sulfate (SDS).
Electron-microscopy of LPS was performed using the negative staining technique. A drop of the LPS solution or LPS-polymyxin B mixture was placed on a carbon coated Formvar grid and stained with 1 % phosphotungstic acid, pH 6.8. The negatively stained material was examined in an Hitachi HU-11 A Electron Microscope at an accelerating voltage of 50 kV.
Polyacrylamide gel electrophoresis in SDS of LPS preparations from resistant and sensitive strains before and after treatment with polymyxin B, as well as isolated LPS after complexing with polymyxin B was carried out in a 5.25 % gel containing 0.5 go SDS in a 0.1 M phosphate buffer, pH 7.1 for 21 hours at 8 mA/tube.
Duplicate gels were stained for protein with coomassie blue, and LPS with a " stains-all " carbocyanine dye.17) All stained gels were scanned on a Beckman ACTA VI Spectrophotometer at 462 nm for gels stained for LPS, at 600 nm for gels Samples were dissolved in a solvent made up of 2.0% SDS, 1.0%, 2-mercaptoethanol, 10 % glycerol in 10 mM phosphate buffer, pH 7.1. 5.25 % Acrylamide gel in 0.05 M phosphate buffer, pH 7.1 was used. actual molecular weight of polymyxin B itself is only 1213, it is likely that this component represents a micelle of polymyxin B with SDS in the gel. The gel patterns of LPS isolated from strain 08 and strain Bizio are shown in Fig. 1-b and 1-d , respectively. In both cases there were two detectable components. The major one (II) in strain 08 had a molecular weight of approximately 18,500 daltons while the similar one in strain Bizio had a slightly lower molecular weight of 17,000 daltons.
These components stained positively for both LPS and protein.
After treatment with polymyxin B, LPS (08) gave three components ( Fig. 1-c ) with molecular weights of 62,500 (I), 28,000 (II) and 16,000 (III) daltons. Similar treatment of LPS from the sensitive strain Bizio gave a complex pattern with multiple peaks ( Fig. 1-e) . In the regions stained positively for LPS (Figs. 2-g and 2-a), a broad band (I) with multiple small peaks was found in the molecular weight range of 47,000-67,000 daltons. In addition, a sharp band (II b) of molecular weight of 27,500 daltons was also found. When the gels were stained for protein, multiple peaks were again found in the region of the broad band I, as well as in a lower molecular weight region of 22,500-25,500 daltons. Components II a and III ( Fig (Fig. 2-a) . Table 1 summarizes the apparent molecular weights of the separated components from various LPS fractions. In the in vitro treated samples, the increases (54 %-56 %) in the apparent molecular weight of the major components (II) from LPS fractions of the resistant cells (08 and 6292) were slightly lower than those (59-62 %) of the LPS fractions from sensitive cells (Bizio and 13378). The increases (6-13 %) in the components of the LPS after in vivo treatment of the resistant cells were significantly lower in comparison with those after in vitro treatment (54-56%).
Thus, it appears that the LPS components in the outer membrane were protected from interacting with the antibiotic during the in vivo treatment. In order to determine the relative amount of polymyxin B complexing with the LPS components, the ratio of the maximum absorbance of the protein stained components to that stained for LPS in the gels was calculated (Table 2) . By this method, an increase in the ratio in the component would indicate binding of polymyxin B to the LPS. On the other hand, a decrease of this ratio could be interpreted as an indication for dissociation and/or degradation of the LPS-protein complex. When the ratios of the various components in the preparations from the resistant cells are compared, it can be seen that the amount of increase after the in vivo treatment (0.6) parallels those after the in vitro treatment (0.5-0.7). This seems to indicate that equal amounts of polymyxin may be binding to the major components of LPS (Fig. 3-d) .
After the in vitro polymyxin B treatment, only a few spheres remained (Fig. 3-e) , with occasional short rods present. The effect of polymyxin B in vitro, on the LPS from the sensitive strains of S. marcescens was similar to that on LPS from E. coli.11) LPS isolated from resistant cells after they were treated with polymyxin B (in vivo treatment) showed a modification of the morphology similar to those of the in vitro treatment.
In addition numerous linear forms were present (Fig. 3-c) . However, LPS from sensitive cells treated in vivo with polymyxin B was degraded into many short rods and a general amorphous mass ( Fig. 3-f ). Table 2 ). The third component had an apparent molecular weight similar to that of the electrophoresed PB.
The ability of the LPS components from the resistant cells to form complexes with PB, indicated that PB not only modified, but also increased the size of the LPS components ( Fig. 3-b) , and had little effect on their stability. On the other hand, the presence of the multiple components in the reaction mixture of LPS from sensitive strains and PB reflected significant degradation of the LPS components by the antibiotic. The large decrease of the protein/LPS ratio from 4.10 to 1.25 clearly indicated that disruption occurred between the protein LPS linkages. Morphologically, these multiple components were assumed to be present as non-resolvable particles (Fig. 3-e) , while the surviving spheres were present as the 27,500 daltons complex (Fig. 2-g ). Similarly, the two populations of spheres (Fig. 3-c ) observed in the in vitro treatment of LPS fractions from resistant cells corresponded to the complex formed in the electrophoretic system, namely, the 60,000 daltons and the 27,500 daltons components (Fig. 2-c and 2-d) .
Despite the presence of various linkages in the LPS-protein complex which may be sensitive to phenol extraction", 21) and mild acetic acid treatment,27) they may be protected in their native state in the outer membrane21) during phenol extraction.
Bonds untouched by phenol treatment may not survive the interaction with PB. Also, the in vivo treatment with PB on the LPS-protein complexes in the cell envelope prior to phenol treatment may not be any less damaging.
Indeed, after in vivo treatment, the LPS components in strain
Bizio were degraded to such extent (Fig. 3-f 
